• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Alora Pharmaceuticals Celebrates Acquisition of Monarch Manufacturing Facility

Share:

January 14, 2023

ALPHARETTA, Ga., Jan. 10, 2023 /PRNewswire/ — Alora Pharmaceuticals, LLC, is pleased to announce that its wholly owned subsidiary, Sovereign Pharmaceuticals, LLC, has acquired, through bankruptcy proceedings, substantially all of Monarch PCM, LLC’s manufacturing capabilities located in Fort Worth, TX. The acquisition, which closed on January 4, 2022, included all of Monarch’s equipment at the site along with an assignment of the leased space, which is located in the same complex as Sovereign’s main facility. The synergy of the acquired equipment and proximity to Sovereign’s current operations will allow Sovereign to expand its current operations into the new footprint after some renovation.

Expansion in Fort Worth, TX supports and enhances the company’s robust manufacturing capabilities.

“The acquisition of the Monarch assets will significantly improve our ability to manufacture solid, semi-solid and liquid manufacturing in large volumes,” according to Art Deas, CEO of Alora. Mr. Deas added that “we are also excited to welcome the majority of Monarch’s former employees into our family, where their added expertise and familiarity with the acquired space and equipment will be invaluable. This is a strategic acquisition that will provide significant opportunities for Alora and our contract manufacturing volume and capabilities.

This acquisition will add 60,000 sq. ft. of manufacturing space that will bring Alora’s total manufacturing footprint to over 300,000 sq. ft. In addition, this acquisition will add 48 employees to the employee base of Alora and its subsidiaries across the United States.

“This acquisition is part of Alora’s ongoing commitment to seek opportunities that will enhance Alora’s manufacturing capabilities in the United States for the benefit of the patients Alora and its partners serve,” said Art Deas.

About Alora Pharmaceuticals, LLC

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Alora Pharmaceuticals, LLC, is the parent company of six specialty pharmaceutical and pharmaceutical manufacturing companies. Alora is Headquartered in Alpharetta, GA. Alora is the parent company of the following organizations that comprise the Alora family of companies, Avion Pharmaceuticals, LLC, Acella Pharmaceuticals, LLC, Osmotica Pharmaceutical US, LLC, Sovereign Pharmaceuticals, LLC, Trigen Laboratories, LLC and Vertical Pharmaceuticals, LLC.

Source: Bio Space

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Health Care Sector Rating: OutperformHealth Care Sector Rating: Outperform
  • Wavely Diagnostics Announces New Funding to Accelerate Commercial Launch, Scale Delivery of Only Digital Diagnostics Platform for Childhood Ear InfectionsWavely Diagnostics Announces New Funding to Accelerate Commercial Launch, Scale Delivery of Only Digital Diagnostics Platform for Childhood Ear Infections
  • Healx Nabs $56M to Expand AI-Driven Drug Discovery Platform for Rare DiseasesHealx Nabs $56M to Expand AI-Driven Drug Discovery Platform for Rare Diseases
  • AI in healthcare: Not human versus machine, human plus machineAI in healthcare: Not human versus machine, human plus machine
  • Cumberland Pharmaceuticals Acquires Sancuso® from Kyowa Kirin North AmericaCumberland Pharmaceuticals Acquires Sancuso® from Kyowa Kirin North America
  • Using Analytics Could be Key to Curbing Medical BiasUsing Analytics Could be Key to Curbing Medical Bias
  • CHG Healthcare Acquires LocumsMart, the Leading Locum Tenens Management SystemCHG Healthcare Acquires LocumsMart, the Leading Locum Tenens Management System
  • A Pharma Funding Overview & Outlook for 2020A Pharma Funding Overview & Outlook for 2020

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications